Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

33818-15-4 - Cytidine-5'-diphosphocholine sodium salt hydrate - Citicoline - J64161 - Alfa Aesar

J64161 Cytidine-5'-diphosphocholine sodium salt hydrate

CAS Number
33818-15-4
Synonyms
Citicoline

Size Price ($) Quantity Availability
10g 61.20
25g 122.00
50g 220.00
Add to Cart Add to Quote Request View Item

Cytidine-5'-diphosphocholine sodium salt hydrate

MDL
MFCD00150508
EINECS
251-689-1

Chemical Properties

Formula
C14H26N4NaO11P2•xH2O
Formula Weight
510.31(anhy)
Form
Powder
Solubility
Soluble in water (100 mg/ml).

Applications

Cytidine-5'-diphosphocholine sodium salt hydrate acts as a neuroprotective agent in situations of hypoxia and ischemia. It is used as biosynthetic intermediate of membrane phospholipids. It is a cerebral vasodilator and inhibits PLA2 activation.

Notes

Stable under recommended storage conditions. Incompatible with oxidizing agents.

Literature References

W.M.Clark; S.J.Warach; L.C.Pettigrew; R.E.Gammans; L.A.Sabounjian. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology. 1997, 49,(3), 671-678.

 

S.Warach, MD, PhD; L.Creed Pettigrew, MD; J.F.Dashe, MD, PhD; P.Pullicino MD; David M.Lefkowitz, MD; L.Sabounjian, RN; K.Harnett, MS; U.Schwiderski, PhD; R.Gammans, PhD. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Annals of Neurology. 2000, 48,(5), 713-722.

Other References

Beilstein
4110040
Harmonized Tariff Code
2934.99
TSCA
No

Recommended

Recently Viewed

Chemicals

Life Science

Metals & Materials

Catalysts

Analytical & Labware